Table 2 Cardiovascular treatments and outcomes according to weaning category (n = 67)
From: Cardiac function during weaning failure: the role of diastolic dysfunction
|  | All patients (n = 67) | Weaning | p | |
|---|---|---|---|---|
Short (n = 49) | Prolonged (n = 18) | |||
Cardiovascular treatments during weaning | Â | Â | Â | Â |
Diuretics | 56 (84) | 38 (78) | 18 (100) | 0.03 |
Dobutamine | 19 (28) | 15 (31) | 4 (22) | 0.50 |
Vasodilator | 30 (45) | 26 (53) | 4 (22) | 0.02 |
Amiodarone | 19 (28) | 13 (27) | 6 (33) | 0.58 |
Any cardiovascular treatment | 62 (93) | 44 (90) | 18 (100) | 0.31 |
Average daily furosemide dose during weaning, mg | 25 (4–59) | 30 (1–59) | 22 (6–56) | 0.94 |
Average daily fluid balance during weaning, mL | − 757 (− 2016 to − 81) | − 1202 (− 2342 to − 477) | 51 (− 638 to 449) | < 0.01 |
Average daily urine output during weaning, mL | 2588 (1971 to 3863) | 2950 (2205 to 4167) | 1967 (1649 to 2912) | 0.02 |
Outcomes | Â | Â | Â | Â |
Time to first successful extubation, days | 2 (1–6) | 1 (1–2) | 13 (10–32) | < 0.01 |
Ventilator free days at day-28, days | 24 (18–27) | 27 (25–27) | 0 (0–16) | < 0.01 |
Time to discharge from ICU, days | 9 (5–18) | 7 (4–10) | 31 (15–53) | < 0.01 |
Time to discharge from hospital, days | 28 (15–53) | 22 (13–32) | 39 (22–53) | 0.07 |
ICU mortality | 9 (13) | 2 (4) | 7 (39) | < 0.01 |
Hospital mortality | 10 (15) | 3 (6) | 7 (39) | < 0.01 |